PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
ConditionTuberculosis (TB)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity College, London
About this trial
This study is part of a broader programme of work to develop and pilot a randomised-controlled trial of new tests to identify people who will benefit most from preventive treatment for tuberculosis (TB). The aim of the current study is to explore factors affecting patient decisions to start preventive treatment. The specific objectives are to understand how patients make decisions about preventive treatment initiation for TB (stage 1); and to design and conduct a "discrete choice experiment" survey to further evaluate preferences (stage 2).
Eligibility criteria
Qualifiers
Adults (aged ≥18 years) who have been tested for latent TB infection in routine clinical services, or are eligible for testing. Eligible people for testing include migrants from countries with high TB incidence (entered UK within 5 years), people with recent contact with a person with TB disease, and people eligible for LTBI screening prior to starting immunosuppression or through occupational health testing.
Disqualifiers
Unable to provide informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
430 Participants
are grouped into 3 trial groupsSponsors and collaborators
University College, London
Lead sponsor
University of Aberdeen
Collaborator
Source ClinicalTrials.gov